• Elisabeth S van Ede, Marlijn P A Hoeks, Jan Hofland, Vera D Linssen, Toin H van Kuppevelt, Elly M Versteeg, Theo G Hafmans, Arjan Diepstra, Benno Kusters, and Sanne M M Vermorgen.
• Department of Intensive Care Medicine, Radboudumc, Nijmegen, the Netherlands.
• BMC Anesthesiol. 2023 Jun 21; 23 (1): 217217.

BackgroundNon-AT-III mediated heparin-resistance during CPB occurs by complex-forming with heparin-binding proteins. Currently, there are no specific recommendations for non-AT-III mediated heparin-resistance.Case PresentationWe present a fatal case of a 70-yr-old male-patient undergoing cardiac-surgery in which refractory heparin-resistance was observed. The massive AL amyloidosis found at autopsy is thought to be responsible and illustrates that awareness and knowledge of the etiology and perioperative strategies of non-AT-III mediated heparin-resistance is important.ConclusionFor anticoagulation during cardiopulmonary bypass surgery in case of a non-AT-III medicated heparin resistance, we refer to the decision tree added to this manuscript and if necessary to consider direct thrombin inhibitors, such as bivalirudin or argatroban, as it bypasses the complexing pathway.© 2023. The Author(s).

15 keywords...

hide…